Position
Chief Executive Officer
Company
NuVision Biotherapies
NottinghamManufacturingBiotechnologyHealth CareMedical DeviceDescription
NuVision Biotherapies has appointed Tim Precious as chief executive to lead the company’s next phase of growth. Starting on 26 May, Precious will focus on transitioning the business from research and development to a commercially driven organization.
Quick answer
NuVision Biotherapies Appoints Tim Precious as Chief Executive Officer (May 26, 2026). NuVision Biotherapies is based in Nottingham, England, United Kingdom.
- Who is the new Chief Executive Officer at NuVision Biotherapies?
- NuVision Biotherapies named Tim Precious Chief Executive Officer, announced May 26, 2026.
- What did NuVision Biotherapies announce on May 26, 2026?
- NuVision Biotherapies has appointed Tim Precious as chief executive to lead the company’s next phase of growth. Starting on 26 May, Precious will focus on transitioning the business from research and development to a commercially driven organization.
- What does NuVision Biotherapies do?
- NuVisio® is a biotechnology research and development spin out company from the University of Nottingham.
- Where is NuVision Biotherapies based?
- NuVision Biotherapies is based in Nottingham, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- NOWDiagnostics, Inc. (May 28, 2026), JenaValve (May 28, 2026), InMode (May 20, 2026) and Poly Medicure (June 2, 2026) also announced leadership changes within 45 days of NuVision Biotherapies.
Source: Fundz verified event record.
Other recent leadership changes in Medical Device and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- NOWDiagnostics Appoints Lisa A. Nibauer as Chief Executive Officer (May 28, 2026)
- JenaValve Appoints Edward Sarnowski as Chief Technology Officer (May 28, 2026)
- InMode Appoints Moshik Itzkovich as Chief Financial Officer (May 20, 2026)
- Poly Medicure Appoints Indranil Mukherjee as Chief Executive Officer, Asia Pacific and India (June 2, 2026)
- STAAR Surgical Appoints Deborah Andrews as Interim Co-Chief Executive Officer and Chief Financial Officer (June 9, 2026)
- Becton Dickinson Appoints Vitor Roque as Chief Financial Officer (May 8, 2026)
Who to call at NuVision Biotherapies, and when
A new leader at NuVision Biotherapies brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day NuVision Biotherapies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NuVision Biotherapies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NuVision Biotherapies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NuVision Biotherapies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NuVision Biotherapies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.